Deliargyris Efthymios
Insider CIK 1751617 · CTSO Chief Medical Officer · PLXP Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CTSO Cytosorbents Corp | A Award deriv | 2025-08-08 | 2025-08-08 | 95,000 | — | $0 | 95,000 | SEC↗ |
| CTSO Cytosorbents Corp | A Award | 2025-08-08 | 2025-08-08 | 70,000 | — | $0 | 473,025 | SEC↗ |
| CTSO Cytosorbents Corp | J Other deriv | 2025-01-17 | 2025-01-22 | 16,233 | — | $0 | 16,233 | SEC↗ |
| CTSO Cytosorbents Corp | X Exercise deriv | 2025-01-17 | 2025-01-22 | 16,233 | — | $0 | 0 | SEC↗ |
| CTSO Cytosorbents Corp | J Other deriv | 2025-01-17 | 2025-01-22 | 16,233 | — | $0 | 16,233 | SEC↗ |
| CTSO Cytosorbents Corp | X Exercise | 2025-01-17 | 2025-01-22 | 16,233 | $1.00 | $16.2K | 403,025 | SEC↗ |
| CTSO Cytosorbents Corp | A Award deriv | 2024-10-04 | 2024-10-08 | 50,000 | — | $0 | 50,000 | SEC↗ |
| CTSO Cytosorbents Corp | A Award deriv | 2024-10-04 | 2024-10-08 | 100,000 | — | $0 | 100,000 | SEC↗ |
| CTSO Cytosorbents Corp | A Award deriv | 2024-04-02 | 2024-04-04 | 86,000 | — | $0 | 86,000 | SEC↗ |
| CTSO Cytosorbents Corp | A Award | 2024-04-02 | 2024-04-04 | 61,000 | — | $0 | 409,433 | SEC↗ |
| CTSO Cytosorbents Corp | A Award deriv | 2024-03-29 | 2024-04-02 | 47,088 | — | $0 | 47,088 | SEC↗ |
| CTSO Cytosorbents Corp | P Buy deriv | 2023-12-13 | 2023-12-15 | 7,894 | — | $0 | 7,894 | SEC↗ |
| CTSO Cytosorbents Corp | P Buy | 2023-12-13 | 2023-12-15 | 22,557 | $1.33 | $30.0K | 348,433 | SEC↗ |
| CTSO Cytosorbents Corp | A Award deriv | 2023-07-07 | 2023-07-11 | 40,000 | — | $0 | 40,000 | SEC↗ |
| CTSO Cytosorbents Corp | A Award deriv | 2023-07-07 | 2023-07-11 | 78,000 | — | $0 | 78,000 | SEC↗ |
| CTSO Cytosorbents Corp | A Award | 2023-07-07 | 2023-07-11 | 55,000 | — | $0 | 331,648 | SEC↗ |
| CTSO Cytosorbents Corp | A Award deriv | 2022-08-10 | 2022-08-12 | 300,000 | — | $0 | 300,000 | SEC↗ |
| CTSO Cytosorbents Corp | A Award deriv | 2022-08-10 | 2022-08-12 | 74,000 | — | $0 | 74,000 | SEC↗ |
| CTSO Cytosorbents Corp | A Award | 2022-08-10 | 2022-08-12 | 55,000 | — | $0 | 228,384 | SEC↗ |
| CTSO Cytosorbents Corp | A Award | 2022-08-10 | 2022-08-12 | 52,000 | — | $0 | 283,384 | SEC↗ |
| CTSO Cytosorbents Corp | A Award deriv | 2021-04-12 | 2021-04-14 | 63,250 | — | $0 | 63,250 | SEC↗ |
| CTSO Cytosorbents Corp | A Award | 2021-04-12 | 2021-04-14 | 40,000 | $8.99 | $359.6K | 183,000 | SEC↗ |
| CTSO Cytosorbents Corp | A Award deriv | 2020-04-12 | 2020-05-05 | 85,500 | — | $0 | 85,500 | SEC↗ |
| CTSO Cytosorbents Corp | A Award | 2020-04-12 | 2020-05-05 | 140,000 | — | $0 | 140,000 | SEC↗ |
| PLXP PLx Pharma Inc. | A Award deriv | 2020-03-20 | 2020-03-24 | 60,000 | — | $0 | 60,000 | SEC↗ |
| PLXP PLx Pharma Inc. | A Award deriv | 2019-03-14 | 2019-03-18 | 60,000 | — | $0 | 60,000 | SEC↗ |
| PLXP PLx Pharma Inc. | A Award deriv | 2018-08-29 | 2018-08-31 | 70,000 | — | $0 | 70,000 | SEC↗ |